Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Ann Surg. 2020 Nov 17;275(6):1165–1174. doi: 10.1097/SLA.0000000000004427

TABLE 3.

Results of Univariate Analysis of csRFS and rPFS for Patient Characteristics, IPMN Variables, and PanIN Variables

Variables n (%) or Mean (SD) csRFS rPFS
Events (n) HR (95% Cl) P Events (n) HR (95% Cl) P
Patient characteristics (n = 126)
 Total cohort 126 (100) 19 30
 Age, mean (SD) 66.85 (11.78) 19 1.01 (0.97–1.05) 0.61 30 1.02 (0.99–1.05) 0.21
Sex
 Male 64 (50.79) 13 1 18 1
 Female 62 (49.21) 6 0.45 (0.17–1.17) 0.10 12 0.64 (0.31–1.32) 0.23
BMI, mean (SD) 26.18 (4.58) 19 1.07 (0.97–1.18) 0.18 30 1.11 (1.03 −1.2) 0.007
 Missing 4 (3.17)
Smoker
 Never 48 (38.1) 8 1 12 1
 Former/current 78 (61.9) 11 1.06 (0.42–2.63) 0.91 18 1.33 (0.64–2.76) 0.45
Diabetes (preop)
 No 107 (84.92) 16 1 24 1
 Yes 19 (15.08) 3 1.16 (0.34–3.97) 0.82 6 1.95 (0.79–4.79) 0.15
Alcohol
 Never/rare 96 (76.19) 15 1 25 1
 Frequent/former 27 (21.43) 3 0.69 (0.2–2.38) 0.56 5 0.82 (0.31–2.15) 0.68
 Missing 3 (2.38)
Family history pancreatic cancer
 No 104 (82.54) 11 1 24 1
 Yes 22 (17.46) 8 2.8 (1.12–6.96) 0.03 6 0.89 (0.36–2.18) 0.80
Previous other malignancy or neoplasm
 No 80 (63.49) 13 1 19 1
 Yes 46 (36.51) 6 0.94 (0.36–2.49) 0.91 11 1.2 (0.57 −2.54) 0.63
Surgical procedure
 Whipple 90 (71.43) 15 1 21 1
 distal/central 36 (28.57) 4 0.62 (0.21–1.88) 0.40 9 1.02 (0.47–2.24) 0.96
Margin
 Negative 36 (28.57) 2 1 7 1
 Positive 90 (71.43) 17 3.58 (0.83–15.49) 0.09 23 1.6 (0.68–3.73) 0.28
IPMN variables (n = 126)
Largest size, cm, mean (SD) 2.5 (1.58) 19 0.95 (0.67–1.35) 0.78 30 0.99 (0.75–1.3) 0.94
 Missing 1 (0.79)
Duct involvement (preop imaging)
 Main/mixed 34 (26.98) 5 1 5 1
 Branch 92 (73.02) 14 0.75 (0.27–2.10) 0.59 25 1.11 (0.42–2.92) 0.83
Papillary growth
 No/focal 68 (53.97) 9 1 17 1
 Moderate/extensive 45 (35.71) 8 1.25 (0.48–3.25) 0.64 8 0.68 (0.29–1.58) 0.37
 Missing 13 (10.32)
Predominant grade of dysplasia
 Low/intermediate 112 (88.89) 16 1 26 not performed
 High 4 (3.17) 1 1.75 (0.23–13.32) 0.59 0
 Missing 10 (7.94)
Highest grade of dysplasia
 Low/intermediate 83 (65.87) 8 1 19 1
 High 41 (32.54) 10 3.15 (1.24–7.98) 0.02 10 1.44 (0.67–3.11) 0.35
 Missing 2 (1.59)
Prevalence of highest grade of dysplasia
 Focal 49 (38.89) 7 1 13 1
 Multifocal/extensive 68 (53.97) 10 1.04 (0.4–2.74) 0.93 13 0.6 (0.28–1.3) 0.20
 Missing 9 (7.14)
Multifocal (≧2 IPMN)
 No 76 (60.32) 10 1 15 1
 Yes 50 (39.68) 9 1.37 (0.55–3.37) 0.50 15 1.63 (0.79–3.35) 0.18
Diffuse gland involvement (≧ 2/3)
 No 82 (65.08) 11 1 23 1
 Yes 15 (11.9) 2 1.17 (0.26–5.3) 0.84 3 0.92 (0.27–3.07) 0.89
 Missing 29 (23.02)
PanIN variables (n = 126)
Synchronous PanIN lesion present
 No 24 (19.05) 4 1 5 1
 Yes 102 (80.95) 15 0.78 (0.26–2.35) 0.66 25 0.59 (0.23–1.56) 0.29
No. of lesions
 <5 68 (53.97) 10 1 15 1
 ≧5 54 (42.86) 9 1.31 (0.53–3.24) 0.55 14 1.31 (0.63–2.71) 0.47
 Missing 4 (3.17)
Highest grade of dysplasia
 Low/intermediate 95 (75.4) 13 1 22 1
 High 6 (4.76) 2 2.95 (0.66–13.14) 0.16 3 2.39 (0.71 −8.03) 0.16
 Missing 25 (19.84)

BMI indicates body mass index; SD, standard deviation. Missing data were not included in the analysis.